A Lancet study published in 2023 stated that cardiovascular diseases (CVD) are the leading cause of death and disability in India. The situation is grave enough that CVD is named as an epidemic. Indians are at risk of developing CVD earlier…
Category: 6. Health
-

First multiple sclerosis patient in the UK receives CAR T cell therapy in groundbreaking trial
A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalized treatment can slow or even halt the progression of the…
Continue Reading
-

GLP-1 RAs May Influence Development of Nonexudative AMD in Patients With Obesity
GLP-1 RA usage is associated with a reduction in risk of developing nonexudative
age-related macular degeneration (AMD) , according to a study comparing GLP-1 RAs, other weight-loss drugs (OWLDs), and no weight-loss medication use.1Research has…
Continue Reading
-

New Breakthrough Treatment Safely Kills Cancer Cells With Light : ScienceAlert
Cancer treatment has come a long way, but many of today’s therapies still come with steep costs: not just financial, but physical and emotional too. Chemotherapy and radiotherapy remain vital tools, yet they often damage healthy cells…
Continue Reading
-

‘It really does seem like it turns out to be’
A new AI system can predict disease risks up to 10 to 20 years before symptoms even occur.
As Innovation Origins reported, researchers developed Delphi-2M using over 40,000 Biobank participants and 1.9 million Danish medical records. It can…
Continue Reading
-

Scientists explore innovative technique for lung health improvements
An unconventional method of delivering oxygen rectally, known as “enteral ventilation,” is advancing through human clinical trials, according to a study.
U.S. and Japanese scientists suggest that a “butt breathing” technique might eventually…
Continue Reading
-

Ribo granted EMA Orphan Drug Designation for siRNA therapeutic RBD1016 for hepatitis delta Virus (HDV) Infection
BEIJING, China & GOTHENBURG, Sweden — 2025-10-24 — Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to RBD1016 for…
Continue Reading
-
Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes – 2 Minute Medicine
- Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes 2 Minute Medicine
- Heart Health in Type 2 Diabetes and GLP-1 Benefits European Medical Journal
- Among T2D Drugs, GLP-1s Top Others for Reducing CV…
Continue Reading
-

Study shows AI-powered wristband improves daily function for people with essential tremor
Everyone’s hands shake a bit, which is why it can be hard to thread a needle or hold a camera steady. But for people with essential tremor, which causes involuntary shaking, most often in the hands, even routine tasks like holding a cup of…
Continue Reading

